Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2
Figure 3

References

  1. 1.

    Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-123. https://doi.org/10.1007/s12350-019-01760-6.

    Article  PubMed  Google Scholar 

  2. 2.

    Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015;22:147-55. https://doi.org/10.3109/13506129.2015.1028616.

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Lawson Research Institute, London, Ontario, Canada.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rami M. Abazid MD.

Ethics declarations

Disclosures

Dr. Cigdem Akincioglu is a consultant for Pfizer. Drs. Rami M. Abazid, Jonathan G. Romsa, James C. Warrington, Robert Z. Stodilka, Ryan A. Davey, Sabe De, David L. Laidley, William C. Vezina, and William C. Vezina have nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abazid, R.M., Romsa, J.G., Warrington, J.C. et al. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J. Nucl. Cardiol. (2021). https://doi.org/10.1007/s12350-020-02508-3

Download citation